ArticleFrontiers in immunology2023

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.

Pin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.